UnitedHealth Group Incorporated reported its second quarter 2026 results.

Management stated, "Total revenues were $112 billion" for the quarter.

The company reported "adjusted earnings per share of $6.38" for the quarter and "operating earnings of $8 billion" which "grew 55% year-over-year". Management noted, "Our reported medical care ratio of 86.7% includes $860 million of net favorable prior period medical development". Furthermore, the quarter was supported by "Operating cash flows in the quarter were approximately $11 billion or 1.9x net income".Executives highlighted progress across segments, noting that UnitedHealthcare "exceeded expectations, driven by better results in Medicare Advantage, while commercial benefits remain pressured". In the commercial business, management is seeing a "medical cost trend modestly above 11%" which they attribute to "the independent resolution process under the No Surprises Act" and "more aggressive billing practices among providers". At Optum, management noted "building momentum from Optum Health as the business recenters back to its integrated value-based care delivery model".Regarding forward guidance, management provided a "new adjusted earnings per share guidance range of $19.50 to $20" for the full year.

The company is also "increasing the full year operating earnings outlook for UnitedHealthcare to at least $12 billion and for Optum Health to at least $2.2 billion". Management now expects "a full year medical care ratio of 88.1%, plus or minus 25 basis points". The company also expects "to complete total share repurchases of at least $5 billion in 2026".Management discussed technology and AI initiatives across the enterprise.

They highlighted that "digital prior authorization powered by AI" is "producing 96% first pass approval". In notable announcements, management noted that on July 2, the company "successfully closed the previously announced combination with Alegeus" and announced a new Optum Rx "pharmacy care approach based on a monthly per member fees with full PBM and GPO fee transparency".

Taiwan Semiconductor Manufacturing Company Limited reported its financial results for the second quarter of 2026.

Management stated they concluded the second quarter with "revenue of USD 40.2 billion". Second quarter gross margin was 67.7%.

Advanced technology accounted for 77% of wafer revenue.

The company noted that 2-nanometer process technology contributed 3% of wafer revenue in the second quarter, while 3-nanometer, 5-nanometer and 7-nanometer accounted for 30%, 33% and 11% respectively.

High performance computing increased 20% quarter-over-quarter to account for 66% of second quarter revenue.

Regarding business updates, management highlighted that "AI-related demand continues to be extremely robust". They noted that the emergence of Agentic AI is leading to a resurgence in the role of CPUs in AI data centers. To support strong structural demand, the company decided to raise its full year 2026 capital budget to be "between USD 60 billion and USD 64 billion". The company also announced "an additional USD 100 billion investment in Arizona" to build several more semiconductor wafer fabs for 2-nanometer and below technologies as well as advanced packaging fabs.

Furthermore, management provided an update on A14 technology, stating development is on track and volume production is scheduled for 2028.

Management also introduced A13 and A12, which are scheduled for volume production in 2029.

For forward guidance, management expects third quarter revenue to be between USD 44.6 billion and USD 45.8 billion.

Based on an exchange rate assumption of USD 1 to TWD 32, third quarter gross margin is expected to be between 65% and 67%, and operating margin between 56% and 58%.

Management noted that the steep ramp-up of 2-nanometer technology is expected to dilute gross margin by about 3 to 4 percentage points in the second half of the year.

For the full year 2026, the company now expects revenue growth to be "slightly above 40% year-over-year in U.S. dollar terms".

On a GAAP basis for the second quarter, "total revenue increased 19%, operating income improved 32% and diluted earnings per share improved 45% compared to the prior year period". Management reported that over the past year, the company has "removed over $135 million of structural costs". During the quarter, the Intermodal segment set a "quarterly volume record with over 578,000 loads", with volumes up 10% year-over-year. In the Highway businesses, JBT reported a fifth consecutive quarter of double-digit volume growth, with revenue increasing 35%, but "gross profit dollars declined 12% primarily due to higher purchased transportation rates".The company experienced strong demand as truckload capacity continued to tighten. As noted by management, "several industry indicators, including higher tender rejections, higher spot pricing and lower driver employment move towards levels not seen since 2021 and 2022". Final Mile demand remained stable across core end markets of furniture, exercise equipment, and appliances.

The Dedicated Contract Services segment reported that its pipeline is "currently at a record level in terms of number of trucks" as the tightening market drove increased customer interest.

Management also highlighted challenges with driver availability, stating there are "specific markets that are as tight as we have ever seen".Regarding forward expectations, the Dedicated Contract Services segment remains confident it will achieve its "full year target for gross truck sales of 1,000 to 1,200 new trucks". Management maintained its expectation that it would return to fleet growth this year while achieving "only modest operating income growth for 2026". For the Intermodal segment, management expects pricing to improve, stating they "anticipate certainly closing that gap" between Intermodal and truckload rates as the year progresses and new business is brought on.

Johnson & Johnson reported its second quarter 2026 financial results, stating that worldwide sales were $25.3 billion for the quarter, which represents a sales increase of 5.6 percent.

Net earnings for the quarter were $5.5 billion, with diluted earnings per share of $2.27.

Adjusted net earnings reached $7.1 billion for the quarter, and adjusted diluted earnings per share were $2.90.

The company reported a year-to-date free cash flow totaling approximately $8.7 billion.

Innovative medicine delivered operational sales growth of 6.8 percent in the quarter, while overall cardiovascular grew 3.1 percent and surgery grew 2.3 percent.

Executives emphasized that they continue to prioritize investments with a focus on supporting commercial launches and advancing future innovation.

Management highlighted that they have a broad durable portfolio featuring 28 platforms that each generate more than $1 billion in annual revenue.

The company noted that acquisitions are an enabler of growth, but they are not a requirement to deliver on their near- and long-term objectives.

Management remains confident that the foundation gives them a clear line of sight to double-digit growth by the end of the decade.In the product pipeline, DARZALEX continued to be the company's largest product, delivering quarterly sales of more than $4 billion and growing close to 18 percent. TREMFYA delivered overall sales growth of 71 percent in the quarter.

Furthermore, the company anticipates FDA approval for the OTTAVA robotic surgical system and plans to launch both OTTAVA and Monarch for urology this year.

The company also pointed to the momentum of recent launches including ICOTYDE, INLEXZO, and RYBREVANT, noting that more than 10,000 patients have initiated therapy on ICOTYDE.For the full year 2026, management is increasing operational sales growth guidance by $400 million, expecting a range of 6.5 percent to 7.1 percent with a midpoint of $100.6 billion.

The company expects full year reported sales growth of 7.0 percent to 7.6 percent, with a midpoint of $101.1 billion.

The company also raised its full year adjusted operational earnings per share range to $11.50 to $11.65, and reported earnings per share for the full year is projected to be between $11.60 and $11.75.

Elevance Health reported second quarter operating revenue that totaled $49.8 billion.

Second quarter adjusted diluted earnings per share were $7.45.

Operating cash flow totaled $1.9 billion in the quarter, and days in claims payable were 45.4 days as of June 30.

During the quarter, the company recorded a net below-the-line benefit of $0.80 per share, which management intends to use to fund one-time investments in the second half of the year.

President and CEO Gail Boudreaux highlighted that the company is accelerating investments in capabilities tied to earlier detection of medical cost trend, more precise clinical intervention, a simpler member experience, and better provider connectivity.

Management noted they are utilizing Sydney Health to improve how members access care and are expanding Carelon value-based solutions like CareBridge, which can generate medical savings in the mid-teens for members. In its Medicaid business, Elevance Health recently reached a mutual agreement to exit the District of Columbia Medicaid market and expects to exit additional Medicaid markets over the next 12 to 18 months where they do not see a path to sustainable performance.

Additionally, the company made an initial remittance to CMS of $342 million in the second quarter and subsequently received written confirmation that sanctions will not be imposed and the matter is closed.

Looking forward, Elevance Health raised its full year 2026 adjusted diluted earnings per share guidance to at least $27.

For 2027, the company remains confident in returning to at least 12% adjusted EPS growth based off a revised 2026 earnings baseline of at least $26.

Management also raised its full year operating cash flow outlook to at least $6 billion.

The company maintained its full year Medicaid operating margin outlook of approximately negative 1.75%, while noting they remain on track to achieve an operating margin of at least 2% in the Medicare Advantage business this year.

For the second quarter of 2026, ASML reported that "total net sales were EUR 9.3 billion". Management noted that "Gross margin for the quarter was above our guidance at 54%". The company stated that "Net income in Q2 was EUR 2.9 billion" and resulted in "earnings per share of EUR 7.59". ASML additionally reported that "free cash flow in Q2 was EUR 1.3 billion".During the call, management highlighted that "Strong end market demand this year has motivated our customers to aggressively add capacity on their leading-edge nodes". Looking ahead to 2027, ASML stated they are "planning to increase our low NA EUV capacity by around 30%" and are also "investigating a further 30% capacity increase" for 2028. In notable product milestones, ASML announced that "Intel foundry is using ASML High NA EUV technology on the Intel 18A process node to produce a subset of its Intel core Ultra-series reprocessors".Providing forward guidance, management shared that they "expect Q3 total net sales to be between EUR 11 billion and EUR 12 billion" and that "Gross margin for Q3 is expected to be between 55% and 57%". For the full year 2026, ASML is "updating our full year 2026 guidance" and now expects "total net sales between EUR 43 billion and EUR 45 billion, with a gross margin between 54% and 56%". Management also expects "memory-related net system sales to grow by over 75% this year".

The Goldman Sachs Group, Inc. reported second quarter 2026 "record revenues of $20.3 billion, record earnings per share of $20.98 and an ROE of 23.5% and an ROTE of 25.5%". For the second quarter, management stated "Global Banking & Markets revenues were a record $15.5 billion in the second quarter". Additionally, "Asset & Wealth Management revenues were up 20% year-over-year to $4.6 billion" in the second quarter.

The company also noted that "firm-wide net interest income was $4 billion in the second quarter" and "Total operating expenses were $11.7 billion for the quarter".During the quarter, management highlighted that "total assets under supervision ended the quarter at a record $4 trillion," which was "supported by $91 billion of long-term net inflows across asset classes". Executives noted that the "investment banking backlog increased to its highest level in 5 years". The firm also reported "record equities intermediation revenues of $4.2 billion" which "increased 60% year-over-year," and mentioned that they "repurchased $4 billion of common stock in the quarter".Regarding forward guidance and strategic themes, management stated "we now expect full year fundraising to exceed $125 billion". For Platform Solutions, they "expect quarterly revenues for the remainder of the year to be broadly consistent with the second quarter". Executives noted that for the full year, "we continue to expect an effective tax rate of approximately 20%". Management also shared that they "expect these fees to increase materially for the remainder of the year" regarding incentive fees.In notable announcements, the firm was "appointed to manage both Verizon and Lockheed Martin's retirement plans, which collectively represents $70 billion in assets under supervision". The company also highlighted their recent advisory work, "acting as a lead left bookrunner on the record-breaking IPO for SpaceX and equity raise for Alphabet". Management additionally mentioned their "recent acquisitions, Industry Ventures and Innovator are both showing solid momentum in the first few months of integration".

Wells Fargo & Company reported its second quarter 2026 results.

Chief Executive Officer Charles Scharf stated, "We grew diluted earnings per share to $2 in the second quarter, up 25% from a year ago." He also noted that "Revenue grew 9% from a year ago." Chief Financial Officer Michael Santomassimo added that "Our earnings increased 17% from a year ago to $6.4 billion." Santomassimo highlighted that "Net interest income increased $609 million or 5% from a year ago" and the company saw "broad-based growth in noninterest income up $1.2 billion or 13% from a year ago."Scharf emphasized the success of the company's efficiency initiatives, indicating this is the "24th consecutive quarter" of headcount reductions.

During the first half of the year, the company "returned over $9.8 billion of capital to shareholders". In the Wealth and Investment Management division, the company "launched Advisor Gateway, a new desktop technology with Gen AI capabilities". The auto business continued its momentum, driven in part by "becoming the preferred financing provider for Volkswagen and Audi vehicles in the U.S."Regarding the 2026 outlook, Santomassimo stated the company is "maintaining our guidance of $50 billion, plus or minus of net interest income for the full year". He further clarified they "still expect net interest income, excluding markets to be approximately $48 billion for the full year" and "still expect markets NII to be approximately $2 billion in 2026". Finally, he confirmed the expense outlook remains unchanged, stating they "still expect 2026 noninterest expense to be approximately $55.7 billion".

JPMorgan Chase & Co. reported second quarter 2026 "net income of $16.9 billion", "EPS of $6.14", and an "ROTCE of 23%". Excluding significant items, quarter revenue was up 15% year-on-year.

Expenses for the quarter of $27.3 billion were up 15% year-on-year.

Credit costs for the quarter were $2.5 billion, featuring net charge-offs of $2.4 billion and a net reserve build of $149 million.

The standardized CET1 ratio ended the quarter at 14.1%.

Management also highlighted that the Board intends to increase the quarterly dividend to $1.65 per share effective in the third quarter.

Management discussed key business and leadership updates, including the elevation of Doug and Troy to co-Presidents.

Executives highlighted artificial intelligence as a major strategic priority, noting there are almost 1,000 use cases today across risk, fraud, marketing, hedging, and prospecting.

They anticipate that AI will bring huge efficiency to certain parts of the firm and noted they are preparing for meaningful acceleration in token expense in the second half of the year. On the consumer side, the firm refreshed the Sapphire Preferred card and outlined its European consumer banking aspirations.

Management noted Chase U.K. has almost 3 million or 2.5 million customers, the firm has opened in Berlin, and they hold the dream of a pan-European successful digital bank.

Management also mentioned testing a Smart Cash tool to compete for investment and deposit business.

For the full year 2026 outlook, the firm now expects net interest income excluding markets to be about $96.5 billion and total net interest income to be approximately $105.5 billion.

The new adjusted expense outlook for the full year is about $107.5 billion, driven primarily by higher volume and revenue-related expenses.

Additionally, management expects the card net charge-off rate to be approximately 3.2% reflecting better-than-expected consumer credit performance.

For the second quarter of 2026, Bank of America Corporation reported strong financial results.

Executive Brian Moynihan stated, "Our revenue grew 15% year-over-year to $31.6 billion" and "Our net income was $9.1 billion, up 27% from last year". He also noted that "Our EPS increased 34% to $1.21 a share". The company generated a "return on tangible common equity of 17%" and "delivered 6.6% operating leverage and our efficiency ratio improved to 59%" for the quarter.

Executive Alastair Borthwick added that "NII on an FTE basis was approximately $16.2 billion" for the second quarter.

Management highlighted broad-based growth across all segments.

Moynihan noted, "Every business segment contributed to our year-over-year growth". Borthwick highlighted Consumer Banking, where "Net income increased 10% year-over-year to approximately $3.3 billion". Digital engagement remains a focus, with Borthwick stating "Digital engagement remains a clear differentiator with roughly 50 million active digital users, more than 24 million active Erica users". Global Markets also performed well, with Borthwick reporting "Sales & Trading revenue, excluding DVA, increased 33% to $7.2 billion". Furthermore, Moynihan emphasized the company's technology initiatives, noting that "over 200,000 teammates are actively using AI-enabled capabilities across our company".Regarding forward guidance, Borthwick provided an update on net interest income, stating, "We now expect full year 2026 NII growth to be at the upper end of that 6% to 8% range". Management also raised their expectations for operating leverage, with Borthwick announcing, "we now expect full year operating leverage to be in the range of 300 to 400 basis points". Additionally, the company reported an overall tax rate of 21.5% for the quarter, which Borthwick noted is "consistent with our full year guidance".